SEC Form 4 · accession 0001855608-26-000003
CareDx, Inc. · CDNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hannah Valantine
Director
Period of report
Jun 12, 2026
Accepted (ET)
Jun 16, 2026 · 5:51 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001217234
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 12, 2026 | A | 9,795 | $0.00 | A | 48,789 | D | |
| Common StockF3 | Jun 15, 2026 | S | 12,103 | $23.1123 | D | 36,686 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.
- F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.
- F3The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.